STLN Starling Oncology, Inc.

NAS · US · Healthcare · Medical Care Facilities · starlingoncology.com

6.430USD-2.28%Mkt Cap: 655.32M $P/E: —1d ago

Starling Oncology, Inc., an oncology company, provides various oncology services in the United States. It operates through three segments: Specialty pharmacy, Patient Services, and Clinical Trials & Other. The company of…

Industry Peers

Medical Care Facilities

Fresenius SE & Co. KGaA

$26.50BUSDP/E 15.6

THC

Tenet Healthcare Corporation

$20.92BUSDP/E 10.1

EHC

Encompass Health Corporation

Fresenius Medical Care AG

$10.92BUSDP/E 11.3

FMS

Fresenius Medical Care AG

$11.01BUSDP/E 10.7

UHS

Universal Health Services, Inc.

$10.29BUSDP/E 7.1

ENSG

The Ensign Group, Inc.

Option Care Health, Inc.

$4.65BUSDP/E 23.5

CON

Concentra Group Holdings Parent, Inc.

$4.64BUSDP/E 23.5

LFST

LifeStance Health Group, Inc.

National HealthCare Corporation

$3.46BUSDP/E 24.9

ACHC

Acadia Healthcare Company, Inc.

$2.72BUSD

AVAH

Aveanna Healthcare Holdings Inc.

$2.69BUSDP/E 9.8

GRDN

Guardian Pharmacy Services, Inc.

$2.58BUSDP/E 39.5

BKD

Brookdale Senior Living Inc.

$2.57BUSD

Key Statistics

Company

Market Cap655.32M USD

Enterprise Value734.31M USD

Revenue (TTM)587.24M USD

Gross Profit76.44M USD

Net Income (TTM)-60.61M USD

Revenue/Share5.81 USD

Last Price6.430 USD

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees641

CountryUS

SectorHealthcare

IndustryMedical Care Facilities

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-38.08

EV/Revenue1.25

P/S1.14

P/B-26.53

EPS (TTM)-0.30

EPS (Forward)—

52W Range

2.32085% of range7.130

52W High7.130 USD

52W Low2.320 USD

Profitability

Gross Margin15.20%

Oper. Margin-2.86%

EBITDA Margin-3.28%

Profit Margin-12.06%

ROE385.53%

ROA-36.81%

Growth

Revenue Growth34.60%

Earnings Growth—

Cash Flow & Leverage

Operating CF-24.59M USD

CapEx (TTM)3.20M USD

FCF Margin1.46%

FCF Yield1.31%

Net Debt63.70M USD

Net Debt/EBITDA-3.30

Balance Sheet

Debt/Equity-6.60

Current Ratio1.36

Quick Ratio1.14

Book Value/Sh-0.25 USD

Cash/Share0.40 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 USD

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)9.000 USD

Upside (mean)+40.0%

Target Range7.000 USD – 11.00 USD

7.000+40.0% to mean11.00

# Analysts5

Ownership

Shares Out.101.92M

Float88.89M

Insiders17.79%

Institutions46.82%

Short Interest

Short Ratio6.4d

Short % Float7.87%

Short % Out.6.92%

Shares Short7.05M

Short (prev mo.)6.88M

Technical

SMA 506.137 (+4.8%)

SMA 2004.420 (+45.5%)

Beta0.42

S&P 52W Chg16.45%

Avg Vol (30d)1.17M

Avg Vol (10d)1.10M

Technical Indicators

RSI (14)51.9

MACD0.0975

MACD Signal0.1451

MACD Hist.-0.0476

BB Upper7.006 USD

BB Middle6.457 USD

BB Lower5.908 USD

BB Width17.00%

ATR (14)0.3674 USD

Vol Ratio (20d)0.80x